HomeXBIT • NASDAQ
add
XBiotech Inc
Previous close
$2.54
Day range
$2.41 - $2.55
Year range
$2.35 - $8.32
Market cap
78.07M USD
Avg Volume
61.82K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 6.34M | -57.66% |
Net income | -1.76M | 86.50% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -5.90M | 59.42% |
Effective tax rate | -1.62% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 152.94M | -18.88% |
Total assets | 178.68M | -17.11% |
Total liabilities | 5.62M | -70.20% |
Total equity | 173.06M | — |
Shares outstanding | 30.49M | — |
Price to book | 0.45 | — |
Return on assets | -8.79% | — |
Return on capital | -9.11% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -1.76M | 86.50% |
Cash from operations | -5.99M | 47.35% |
Cash from investing | -51.00K | 91.87% |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -2.96M | 76.35% |
Free cash flow | -5.18M | 43.27% |
About
XBiotech Inc. is a clinical-stage biopharmaceutical company based in Austin, Texas. It specializes in the research and development of human-derived antibody therapeutics for multiple diseases, including cancer, rheumatological, and infectious diseases. Wikipedia
Founded
2005
Headquarters
Website
Employees
92
